AgTech Startup 3Bar Biologics Secures $2 Million

3Bar Biologics announced the close of $2 million in financing. Six investors contributed to the round: Rev1 Ventures, Maumee Ventures, Ohio TechAngels Fund, Queen City Angels, SVG Ventures, and Carmen Innovations.

3Bar Biologics is a bioscience company on a mission to apply disruptive technologies to create ecologically sound products that sustainably increase yields and protect farmer’s investments in land and seed. 3Bar’s first product is Bio-YIELD, an all-natural, sustainable microbial inoculant system. Bio-YIELD was introduced to the market in 2014, serving eastern Corn Belt growers.

In its announcement, the company said 3Bar Biologics intends to use the funds to broaden availability of its products.